In addition, in this study we are the first to demonstrate its inhibitory role on malignant behavior of colon cancer in vitro and in vivo and identified the possible underlying molecular mechanism of its action through modulation of JAK-STAT signaling. The gene discussed is SOAT1; the disease is malignant colon neoplasm.